Company Name or Ticker Symbol
Search for other Categories
Dynasil Corp Of America  (DYSL)
Other Ticker:  
    Sector  Capital Goods    Industry Industrial Machinery and Components
Price: $1.2100 $0.00 0.000%
Day's High: $ 1.22 Week Perf: 0.00
Day's Low: $ 1.21 30 Day Perf: 0.00
Volume (M): 7 52 Wk High: $ 1.50
Volume (M$): $ 9 52 Wk Avg: $ 1.22
Open: 1.22 52 Wk Low: 0.89
  DYSL Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 20
 Shares Outstanding (Millions) 17
 Employees 230
 Revenues (TTM) (Millions $) 40
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 1
Dynasil Corp Of America

Dynasil Corporation of America was founded as a New Jersey corporation in 1960 and incorporated in the state of Delaware through a migratory merger in March 2008. Our corporate headquarters are located at 313 Washington Street, Suite 403, Newton, MA 02458, and our corporate website is www.dynasil.com.

We have three reporting segments based on our main operating activities, as well as a fourth segment substantially all of the assets of which were sold in the first quarter of 2014. Below is a summary of these segments:

Contract Research: The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (“RMD”) business unit, which is among the largest small business participants in U.S. government-funded research.

Optics: The Optics segment encompasses four business units – Dynasil Fused Silica, Optometrics, Hilger Crystals, and Evaporated Metal Films – that manufacture commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications.

Biomedical: The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation (“Dynasil Biomedical”), a medical technology incubator which owns rights to certain early stage medical technologies. In October 2013, Dynasil Biomedical formed Xcede Technologies, Inc. (“Xcede”), a joint venture with Mayo Clinic to spin out and separately fund the development of a tissue sealant technology. At September 30, 2015, Dynasil Biomedical owned 90% of the common stock of Xcede (approximately 69%, assuming conversion of the $2.0 million of the outstanding convertible notes), and therefore Xcede is included in our consolidated financial statements. Dynasil Biomedical currently has no operations other than relating to its equity ownership in Xcede.

Instruments: The Instruments segment consists of Dynasil Products (formerly known as RMD Instruments), which manufactured precision instrumentation for medical and commercial applications until the sale in fiscal 2014 of our lead paint detector and gamma medical probe businesses, which together comprised substantially all the operations within our Instruments segment.

DYSL is expected to report next financial results on August 11, 2017.

Dynasil Of America's Segments
  Company Estimates  
  Revenue Outlook
Dynasil Of America does not provide revenue guidance.

Earnings Outlook
Dynasil Corp Of America does not provide earnings estimates.

Geographic Revenue Dispersion

Dover Corp

Strong Results

Dover Corp had impressive second quarter, where profits soared by 36.84 % to $1.04 per share, followed by Sales increase of 18.21 % to $1.99 billions, compared with the prior year period.

Omnicom Group Inc.

Modest Earnings Increase, Sales Down Slightly

Although revenue fell in the second quarter, company managed to grow it's earnings per share, earnings grew modestly by 2.94 % to $1.40 per share while Sales fell by -2.44 % to $3.79 billions, year on year.

DYSL's Valuation Current
Price to Earnings PE Ratio (TTM) 5.73
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.51
Price to Sales (Expected) -
Price to Book 1
PEG (TTM) 0.01
DYSL's Financial Strength Current
Quick Ratio 0.4
Working Capital Ratio 2.03
Leverage Ratio (MRQ) 0.44
Total Debt to Equity 0.18
Interest Coverage (TTM) 6.61
Debt Coverage (TTM) 0.5
Per Share Current
Earnings (TTM) 0.21 $
Revenues (TTM) 2.38 $
Cash Flow (TTM) 0.09 $
Cash 0.14 $
Book Value 1.21 $
Dividend (TTM) 0 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
DYSL's Efficiency Current
Revenue per Employee (TTM) 174,652
Net Income per Employee (TTM) 12,843
Receivable Turnover Ratio (TTM) 10.31
Inventory Turnover Ratio (TTM) 6.51
Asset Turnover Ratio (TTM) 1.48
DYSL's Profitability Ratio Current
Gross Margin 37.56 %
Operating Margin -
Net Margin -
Net Cash Flow Margin 6.69 %
Effective Tax Rate (TTM) -
Management Effectiveness Current
Return On Assets (TTM) 10.91 %
Return On Investment (TTM) 14.94 %
Return On Equity (TTM) 16.86 %
Dividend Yield -
Payout Ratio (TTM) -
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness

You need to upgrade your Flash Player

You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com